TTLC 2026 is a must-attend event for anyone dedicated to advancing lung cancer care.

This landmark meeting convenes leading experts in thoracic oncology to share the latest breakthroughs in clinical research and targeted therapies. With a focus on innovation, collaboration, and impact, TTLC 2026 offers a unique opportunity to engage with a diverse, global community at the forefront of lung cancer treatment.

Top reasons to attend:

Engage with Breakthrough Science

Gain early access to cutting-edge research, preclinical insights, and data from the latest clinical trials focused on targeted therapies for thoracic malignancies.
Learn from Global Experts

Hear directly from world-renowned researchers and clinicians through expert-led sessions and panel discussions on emerging molecular targets and novel treatments.
Connect and Collaborate

Build meaningful connections with peers, industry leaders, and investigators during structured networking events designed to foster collaboration and innovation.
Stay Current with Evolving Standards

Deepen your understanding of how emerging targeted therapies are shaping treatment guidelines and transforming clinical practice in lung cancer.

Join us for the IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) Meeting in Huntington Beach, California. This premier event brings together leading researchers, clinicians, and industry experts to explore the latest breakthroughs in targeted therapies for thoracic malignancies.

TTLC 2026 will feature cutting-edge research, early clinical trial data, and expert-led discussions across a range of molecular targets. With a strong focus on collaboration and innovation, the meeting offers outstanding opportunities to connect, exchange ideas, and shape the future of lung cancer care.

We look forward to welcoming you to Huntington Beach, in February 2026!

Stay Connected